bluebird bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017 - 2011
Net Income	-266.58	-819.38	-618.7	-789.61	-555.63	Upgrade
Depreciation & Amortization	5	19.65	19.36	17.43	17.16	Upgrade
Share-Based Compensation	35.19	127.92	156.63	160.63	110.84	Upgrade
Other Operating Activities	-126.56	36.18	-27.64	47.16	14.21	Upgrade
Operating Cash Flow	-352.95	-635.64	-470.35	-564.38	-413.43	Upgrade
Capital Expenditures	93.79	-14.5	-28.99	-71.03	-55.74	Upgrade
Acquisitions	0	110.3	0	0	0	Upgrade
Change in Investments	161.66	475.26	-55.36	584.06	-623.7	Upgrade
Other Investing Activities	-5	-8.5	-	-5.22	-	Upgrade
Investing Cash Flow	250.45	562.56	-84.35	507.81	-679.44	Upgrade
Share Issuance / Repurchase	54.25	80.33	546.72	21.19	735.61	Upgrade
Debt Issued / Paid	0	0	0	0	-1.02	Upgrade
Other Financing Activities	-	-174.28	-	-	3.1	Upgrade
Financing Cash Flow	54.25	-93.95	546.72	21.19	737.69	Upgrade
Net Cash Flow	-48.25	-167.04	-7.98	-35.39	-355.17	Upgrade
Free Cash Flow	-259.16	-650.14	-499.34	-635.41	-469.16	Upgrade
Free Cash Flow Margin	-7204.92%	-17753.74%	-	-	-859.60%	Upgrade
Free Cash Flow Per Share	-3.30	-9.44	-8.03	-11.51	-9.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).